Laurent Frenzel, MD, PhD1*, Kaan Kavakli2*, Andrew D. Leavitt, MD3, Ali Bülent Antmen, MD, PhD4*, Davide Matino, MD, MSc5,6*, Margareth Ozelo, MD7, Hazza Alzahrani, MD8*, Barbara A. Konkle, MD9, Maria de los Angeles Resa, PhD10*, Annie F. Fang, MD, PhD10*, Jasmine Healy, PhD11*, Delphine Agathon, PhD12*, Francesca Biondo, MD13* and Frank Plonski, MA, RN, BS14*
1Department of Haematology, Institut Necker, Paris, France
2Division of Hematology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey
3Department of Medicine and Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
4Department of Pediatric Hematology, Acibadem Adana Hospital, Adana, Turkey
5McMaster University, Hamilton, ON, Canada
6Thrombosis and Atherosclerosis Research Institute (TaARI), Hamilton, ON, Canada
7Hemocentro UNICAMP, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, Brazil
8Adult Hematology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
9Washington Center for Bleeding Disorders and the University of Washington, Seattle, WA
10Pfizer Inc, New York, NY
11Pfizer Canada ULC, Kirkland, QC, Canada
12Pfizer Inc, Paris, France
13Pfizer S.r.l., Rome, Italy
14Pfizer Inc, Collegeville, PA